Search results for " progression"

showing 10 items of 1092 documents

Biomaterial-Induced Sarcoma

2000

In the study of carcinogenesis most interest has focused on carcinomas, as they represent the majority of human cancers. The recognition of the adenoma-carcinoma sequence both in humans and in animal experimental models has given the field of basic oncology the opportunity to elucidate individual mechanisms in the multistep development of carcinoma. The relative scarcity of human sarcomas coupled with the lack of adequate animal models has hampered understanding of the molecular genetic steps involved. We present an experimental model in the rat in which a high incidence of malignant mesenchymal tumors arise around a subcutaneously implanted biomaterial. Nine commercially available biomater…

Pathologymedicine.medical_specialtyMesenchymal stem cellBiologyMalignancymedicine.diseasemedicine.disease_causePathology and Forensic MedicineTumor progressionmedicineCarcinomaImmunohistochemistrySarcomaCarcinogenesisPreneoplastic ChangeThe American Journal of Pathology
researchProduct

Comparative study of T84 and T84SF human colon carcinoma cells: in vitro and in vivo ultrastructural and functional characterization of cell culture …

2005

To better understand the relationship between tumor heterogeneity, differentiation, and metastasis, suitable experimental models permitting in vitro and in vivo studies are necessary. A new variant cell line (T84SF) exhibiting an altered phenotype was recently selected from a colon cancer cell line (T84) by repetitive plating on TNF-alpha treated human endothelial cells and subsequent selection for adherent cells. The matched pair of cell lines provides a useful system to investigate the extravasation step of the metastatic cascade. Since analysis of morphological differences can be instructive to the understanding of metastatic potential of tumor cells, we compared the ultrastructural and …

Pathologymedicine.medical_specialtyProgrammed cell deathColon carcinoma ; Tumor cells;. Ultrastructure ; Metastasis .;Apoptosis . ;Bcl-XL;Bcl-XLbcl-X ProteinColon carcinomaApoptosis. UltrastructureBiologyAdenocarcinomaMetastasis .Pathology and Forensic MedicineMetastasischemistry.chemical_compoundMicroscopy Electron TransmissionIn vivoCell Line TumorTumor cellmedicineBiomarkers TumorHumansNeoplasm MetastasisMolecular BiologyCell NucleusCytoplasmic VesiclesTyrosine phosphorylationCell BiologyGeneral Medicinemedicine.diseaseApoptosis .In vitroPhenotypechemistryPleomorphism (cytology)ApoptosisCell cultureGelatinasesColonic NeoplasmsCancer researchDisease ProgressionSignal Transduction
researchProduct

KLEIP Deficiency in Mice Causes Progressive Corneal Neovascular Dystrophy

2012

PURPOSE. The BTB-kelch protein KLEIP/KLHL20 is an actin binding protein that regulates cell-cell contact formation and cell migration. The aim of our study was to characterize KLEIP’s function in ocular health and disease in mice. METHODS. KLEIP -/- mice were generated, and corneas were examined histologically and stained for keratin-1, loricrin, keratin-12, keratin-14, CD31, LYVE-1, F4/80, E-cadherin, and Ki67. Corneal abrasions were performed after eyelid opening. RESULTS. Corneas of KLEIP þ/þ and KLEIP -/- mice were indistinguishable at birth. After eyelid opening corneal epithelial hyperplasia started to manifest in KLEIP -/- mice, showing a progressive epithelial metaplasia leading to …

Pathologymedicine.medical_specialtyStromal cellGenotypeMice TransgenicCorneal dystrophyReal-Time Polymerase Chain ReactionCorneaMiceCorneal OpacityCorneamedicineAnimalsCorneal NeovascularizationRNA MessengerAdaptor Proteins Signal TransducingCorneal epitheliumintegumentary systembusiness.industryDystrophymedicine.diseaseeye diseasesEpitheliumMice Inbred C57BLDisease Models Animalmedicine.anatomical_structureGene Expression RegulationDisease ProgressionEpithelial MetaplasiaLoricrinsense organsCarrier ProteinsbusinessInvestigative Opthalmology & Visual Science
researchProduct

Does expression of receptor tyrosine kinases in gastric adenocarcinoma correlate with clinicopathological parameters?

2009

Introduction: The prognosis for patients with gastric cancer depends on the stage of the disease. Radical surgery and lymph node dissection represent the only curative intent and are the standard therapeutic option for patients with limited disease. As new multi-targeted receptor tyrosine kinase inhibitors (RTK) are ermerging in the therapy of diverse malignomas, our aim was to analyze the relevance of the targeted receptor tyrosine kinases on local growth, lymphatic dissemination and overall survival in gastric adenocarcinoma. Methods: The (co-)expression pattern of VEGFR1, VEGFR2, VEGFR3, PDGFRα, PDGFRβ and EGFR1 was analyzed by RT-PCR in 56 consecutive samples of human gastric adenocarci…

Pathologymedicine.medical_specialtybiologybusiness.industryStomachCancermedicine.diseasedigestive system diseasesReceptor tyrosine kinasemedicine.anatomical_structureTumor progressionmedicinebiology.proteinCancer researchAdenocarcinomaStomach cancerbusinessLymph nodeSurvival rate
researchProduct

The ins and outs of osteopontin.

2015

The continuous remodeling of progressing tumors demands non-physiologic production of extracellular matrix (ECM) proteins. Among them, osteopontin (OPN) has been largely involved in tumor progression and metastasis. We have recently discovered a new mechanism for OPN in the metastatic spread of mammary carcinoma providing local immunosuppression at the seeding site.

Pathologymedicine.medical_specialtybiologymedicine.medical_treatmentImmunologyImmunosuppressionMetastasimedicine.diseaseMetastasisMammary carcinomaExtracellular matrixOncologystomatognathic systemTumor progressionMyeloid-derived suppressor cellbiology.proteinCancer researchMyeloid-derived Suppressor CellmedicineImmunology and AllergyOsteopontinOsteopontinAuthor's ViewMetastasis; Myeloid-derived suppressor cells; Osteopontin; Immunology and Allergy; Oncology; ImmunologyOncoimmunology
researchProduct

Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease

2021

AbstractAim of these revised recommendations for the general management of Kawasaki disease is to encourage its prompter recognition and warrant the most appropriate therapy, based on ascertained scientific data, raising awareness of the complications related to misdiagnosis or delayed treatment. A set of 20 synthetic operative statements is herein provided, including the definition of Kawasaki disease, its protean presentations, clinical course and seminal treatment modalities of all disease phases. The application of these recommendations should improve prognosis of Kawasaki disease and prevent the progression to permanent vascular abnormalities, thereby diminishing morbidity and mortalit…

Pediatricsmedicine.medical_specialty2019-20 coronavirus outbreakAspirin; Children; Coronary artery abnormalities; Intravenous immunoglobulin; Kawasaki diseaseReview030204 cardiovascular system & hematologyMucocutaneous Lymph Node SyndromeDiagnosis Differential03 medical and health sciences0302 clinical medicine030225 pediatricshemic and lymphatic diseasesmedicineHumansChildCoronary artery abnormalitieChildrenIntravenous immunoglobulinAspirinAspirinKawasaki diseasebusiness.industryClinical courselcsh:RJ1-570Immunoglobulins Intravenouslcsh:PediatricsGeneral MedicineDelayed treatmentmedicine.diseasePrognosisSettore MED/38Disease phasesSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAEl NiñoItalyTreatment modalityDisease ProgressionAspirin Children Coronary artery abnormalities Intravenous immunoglobulin Kawasaki diseaseKawasaki diseasebusinessCoronary artery abnormalitiesmedicine.drug
researchProduct

Slowly progressive aphasia: a four-year follow-up study

2001

This paper reports the long-term follow-up of GC, a patient with primary progressive aphasia of the fluent type. GC presented at onset with an anomia characterized by sparing of first letter knowledge, that applied mainly to proper names and living categories. No semantic deficits were observed in the first stage of the disease, and MRI showed a left temporal lobe atrophy with a gradient from the pole to the posterior regions, the latter being less involved. We now report the clinical evolution of GC from the 2nd to the 4th year of disease. As the disease progressed, the anomia became more severe and the phenomenon of first letter sparing was no longer detectable. Also semantic knowledge wa…

Pediatricsmedicine.medical_specialtyCognitive NeuroscienceSemantic dementiaExperimental and Cognitive PsychologyNeurological disorderNeuropsychological TestsTemporal lobePrimary progressive aphasiaBehavioral NeuroscienceAtrophyAphasiamedicineHumansSemantic memoryLanguage disorderMiddle Agedmedicine.diseaseSemanticsAphasia Primary ProgressiveDisease ProgressionFemalemedicine.symptomCognition DisordersPsychologyNeuroscienceFollow-Up StudiesNeuropsychologia
researchProduct

Epidemiology, Clinical Features and Prognostic Factors of Pediatric SARS-CoV-2 Infection: Results From an Italian Multicenter Study

2021

Background: Many aspects of SARS-CoV-2 infection in children and adolescents remain unclear and optimal treatment is debated. The objective of our study was to investigate epidemiological, clinical and therapeutic characteristics of pediatric SARS-CoV-2 infection, focusing on risk factors for complicated and critical disease.Methods: The present multicenter Italian study was promoted by the Italian Society of Pediatric Infectious Diseases, involving both pediatric hospitals and general pediatricians/family doctors. All subjects under 18 years of age with documented SARS-CoV-2 infection and referred to the coordinating center were enrolled from March 2020.Results: As of 15 September 2020, 75…

Pediatricsmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MIS-CDisease030204 cardiovascular system & hematologyPediatrics03 medical and health sciences0302 clinical medicinechildren030225 pediatricsEpidemiologymedicinebookOriginal Researchmultisystem inflammatory syndromeMIS-C COVID-19business.industrySARS-CoV-2 infectionDisease progressionlcsh:RJ1-570COVID-19lcsh:PediatricsSettore MED/38Icu admissionCOVID-19; MIS-C; SARS-CoV-2 infection; children; multisystem inflammatory syndromeMulticenter studyPediatrics Perinatology and Child HealthPediatric Infectious Diseasebook.journalbusiness
researchProduct

Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation

2021

Objectives: Optimized diagnostic algorithms to detect active infections are crucial to achieving HCV elimination. We evaluated the cost effectiveness and sustainability of different algorithms for HCV active infection diagnosis, in a context of a high endemic country for HCV infection. Methods: A Markov disease progression model, simulating six diagnostic algorithms in the birth cohort 1969‐1989 over a 10‐year horizon from a healthcare perspective was used. Conventionally diagnosis of active HCV infection is through detection of antibodies (HCV‐Ab) detection followed by HCV‐RNA or HCV core antigen (HCV‐Ag) confirmatory testing either on a second sample or by same sample reflex testing. The …

Pediatricsmedicine.medical_specialtyCost effectivenessCost-Benefit Analysiscost-effectiveneContext (language use)HepacivirusAntiviral AgentsLiver diseaseMedicineHumansbusinesshealth care economics and organizationsHepatologybusiness.industryscreeningDisease progressionHCV chronic infectionvirus diseasesDiagnostic algorithmshealthHepatitis CHepatitis C Chronicmedicine.diseaseHepatitis CHcv eliminationdigestive system diseasesWHO targetHcv core antigenbusinessAlgorithms
researchProduct

Mucopolysaccharidosis Type VII (Sly disease) survivors

2013

treatment. Onset of neurological symptoms at age 8 and in adolescence. Pair 4: L.M. died at age 5 months due to liver failure. P.M. (7 years): earlyinfantile form, despite treatment start at age 2 progressive neurological deterioration. Pair 5: R.K.: late-infantile form, untreated, died at age 9 due to progressive neurological involvement. M.K.: late infantileform, start of treatment at age 5, died at age 13 due to epileptic encephalopathy. These cases reveal that disease onset and progression in siblings with NPC vary, and that miglustat can slow disease progression.

Pediatricsmedicine.medical_specialtyDisease onsetbusiness.industryEndocrinology Diabetes and MetabolismEpileptic encephalopathyMucopolysaccharidosisLiver failuremedicine.diseaseBiochemistryEndocrinologyMiglustatGeneticsmedicineSly diseaseSlow disease progressionbusinessMolecular Biologymedicine.drugMolecular Genetics and Metabolism
researchProduct